• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    MELA Sciences, Inc. (MELA)

    1.16 Up 0.01(0.87%) Jul 2, 4:00PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    MELA Sciences, Inc.
    50 South Buckhout Street
    Suite 1
    Irvington, NY 10533
    United States - Map
    Phone: 914-591-3783
    Fax: 914-591-3785
    Website: http://www.melasciences.com

    Index Membership:N/A
    Industry:Medical Instruments & Supplies
    Full Time Employees:32

    Business Summary 

    MELA Sciences, Inc., a medical device company, designs and develops software-driven technology for the early detection of skin cancer to dermatologists in the United States. The company focuses on commercialization of its principal product MelaFind, a non-invasive point-of-care instrument to aid in the detection of melanoma. Its product consists of a hand-held component that emits light of multiple wavelengths to capture digital data from clinically atypical pigmented skin lesions, which is then analyzed utilizing classification algorithms trained on its proprietary database of melanomas and benign lesions to provide information to assist in the management of the patientÂ’s disease, including information useful in the decision of whether to biopsy the lesion. The company was formerly known as Electro-Optical Sciences, Inc. and changed its name MELA Sciences, Inc. in April 2010. MELA Sciences, Inc. was founded in 1989 and is based in Irvington, New York.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on MELA Sciences, Inc.

    Key Executives 
    Mr. Jeffrey Francis O'Donnell Sr., 55
    Exec. Chairman and Member of Compensation Committee
    Mr. Robert W. Cook , 59
    Chief Financial Officer, Sec. and Treasurer
    Diana Garcia Redruello MIA,
    Managing Director of Europe and VP of Global Marketing
    Dr. Darrell S. Rigel M.D., Ms, Faad, 64
    Chief Medical Advisor and Member of Scientific & Medical Advisory Committee
    Dr. Dina Gutkowicz-Krusin Ph.D.,
    Director of Clinical Studies
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders